Join Dr. Linda Anegawa, Chief Medical Officer at Noom, as she delves into why the success of GLP-1 therapy hinges on lifestyle changes. Discover insights into Noom's clinical support for payers in treating obesity, including managing GLP-1 medications, and learn about the integration of medication management with lifestyle modification techniques for optimal health outcomes.
This episode is sponsored by Noom.
